re.Mind Capital

Alena uses neuroscience-based games to assess the user’s behaviour and identify thinking patterns that drive key mental health disorders. Using this deeper understanding, Alena suggests the most optimal intervention and dynamically adapts to the user's changing needs. Alena was founded in 2019 in London bringing together leading figures from the world of computational neuroscience, psychiatry and user-centric innovation. You can learn more about Alena on our website: www.alena.com

Centenara Labs is a biotechnology company that focuses on developing innovative drug therapies aimed at improving and prolonging human lifespan. Founded in 2019 and headquartered in Zug, Switzerland, the company invests in research and technologies that target age-related diseases. Centenara Labs operates as a fully integrated platform, providing a range of services including drug discovery expertise, financial support, and administrative services. Its mission is to advance scientific understanding and create effective solutions that enable individuals to experience healthier and longer lives.

OccamzRazor is a San Francisco-based AI-neuroscience startup dedicated to developing disease-modifying treatments for Parkinson's Disease and other complex ailments. The company employs a computational approach that leverages both structured and unstructured biomedical data, including published literature and clinical trial results. By constructing a comprehensive knowledge graph that encapsulates all known information about Parkinson's Disease, OccamzRazor facilitates enhanced therapeutic insights and informed decision-making in biomedical research. This platform aims to identify new therapeutic targets and support strategic drug development, addressing the multifactorial nature of complex diseases like Parkinson's.

CereGate GmbH, founded in 2019 and headquartered in Hamburg, Germany, with an additional office in San Diego, California, focuses on developing innovative brain-machine interface technology. The company's software platform enhances the programming of neuromodulation systems, including implants placed in the brain or spinal cord. This technology aims to support patients with neurological disorders or sensory deficits by enabling novel therapeutic approaches and improving their ability to adapt and manage their conditions independently. CereGate's advancements pave the way for new communication methods and therapeutic options, contributing to significant improvements in patient outcomes.

Neumora Therapeutics operates as a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience.

Developer of clinical-stage neuroscience therapeutics intended to harness novel neuroplasticity-promoting treatments for difficult-to-treat neuropsychiatric and neurological disorders. The company's compounds include non-hallucinogenic, non-psychotomimetic, and non-dissociative versions of psychedelic components, enabling healthcare service providers to address significant mental health challenges through phenotypic drug discovery across various chemotypes and mechanisms of action.

Developer of clinical-stage neuroscience therapeutics intended to harness novel neuroplasticity-promoting treatments for difficult-to-treat neuropsychiatric and neurological disorders. The company's compounds include non-hallucinogenic, non-psychotomimetic, and non-dissociative versions of psychedelic components, enabling healthcare service providers to address significant mental health challenges through phenotypic drug discovery across various chemotypes and mechanisms of action.

TRIPP Inc. is a company that specializes in developing virtual reality experiences aimed at enhancing emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a development office in Chicago, TRIPP combines audio-visual elements, gameplay mechanics, and meditation to create immersive experiences that positively influence mood and mental states. Drawing on research indicating that interactive digital experiences can affect brain function, TRIPP positions itself as a pioneer in the intersection of gaming and mindfulness. By leveraging their expertise in game design, the company seeks to redefine the traditional notion of gaming, focusing on the potential of their products to serve as tools for emotional transformation rather than mere entertainment. Ultimately, TRIPP aims to help users achieve desired emotional states, fostering a unique mind-body connection through their innovative offerings.

Ksana Health focuses on collecting data related to mental health and transfer that data from users to healthcare practitioners through an app.

Synchron Inc., based in San Mateo, California, is a developer of advanced medical devices that facilitate brain-computer interfaces. The company specializes in an implantable stentrode, a minimally invasive device that is delivered to the brain via catheter. This device is equipped with electrode arrays that record neuron signals and interpret brain activity, allowing individuals with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies through thought alone. By bridging the gap between neural signals and device operation, Synchron aims to enhance the quality of life for patients with mobility challenges.

Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into a novel, implantable clinical solutions that improve human lives.

CB Therapeutics is a biotechnology company focused on the biosynthetic production of cannabinoids and psychedelic medicines. Utilizing a cellular agriculture platform, the company produces pure cannabinoids such as CBD and THC from sugar using yeast, eliminating the need for plant-based sources. This innovative approach aims to facilitate clinical research into various serious health conditions, particularly in the realms of mental health and overall healthspan. By offering tryptamines, cannabinoids, and their analogs, CB Therapeutics seeks to address pressing healthcare challenges and contribute to the development of effective treatments.